Mounting evidence implicates the dysfunction of GABAergic signaling in the etiology of psychiatric disorders (19, 47), including addiction, PTSD, and MDD, where reduced SST expression in the human amygdala has been observed in postmortem tissue (32, 48). The gene discussed is SST; the disease is major depressive disorder.